Delivery Order SPE2DB20D1110-SPE2DB25FK09X

Award Date 4/21/25
Potential Completion Date 4/22/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,737.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order contract for the supply of Mestinon 180 mg Timespan medication. The contract has an ultimate completion date of April 24, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
This federal contract award from the Defense Logistics Agency (DLA) is a Delivery Order valued at $2,304.73 with Amerisourcebergen Drug Corp as the prime contractor. The contract is for the supply of MESTINON 180 MG TIMESPAN medication, with a completion date of November 19, 2024. It is a Firm Fixed Price contract, with no set-aside designation indicated. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has an Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $4,419.66 Firm Fixed Price delivery order is for the supply of 4,564,340 units of the prescription medication Mestinon 180 mg Timespan with an ultimate completion date of April 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a wide range...
This federal contract award, worth $18,728.40, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Mestinon 180 mg TimeSpan medication. This is a firm fixed-price delivery order contract with a completion date of May 9, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,047.18 firm fixed-price delivery order is for MESTINON 180 MG TIMESPAN UU 30S medication, with a period of performance through November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $3,732.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of February 28, 2025. It is not designated with a set-aside requirement, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,691.14, is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a prescription medication. The contract has an ultimate completion date of December 3, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $14,510.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product, with a completion date of November 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,355.78, is a delivery order for the supply of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract has an ultimate completion date of November 1, 2024 and was awarded on October 31, 2024. It is a firm fixed price contract with no set-aside designation, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,187.77, is for the delivery of MESTINON 180 MG TIMESPAN UU 30S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 4, 2025. This contract award is not associated with a set-aside designation....
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB25FK09X
    Delivery Order

This federal contract award, valued at $5,577.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mestinon 180 mg Timespan tablets and is a firm fixed-price delivery order with an ultimate completion date of April 22, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle with a performance period through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract award does not mention any set-aside designation, indicating open competition.

Generated 7/21/25, 7:49 PM